The Report

Deep dives into company funding, growth strategies, and market insights from the world's most innovative businesses

167 reports and counting

Updated daily with latest market intelligence
Fundraising
MapLight Therapeutics

MapLight Therapeutics Raises $372.5M in Series D

MapLight Therapeutics, a HealthTech company based in San Francisco, CA, has raised $372.5M in Series D at a $2B valuation led by Andreessen Horowitz Bio, 8VC.

Fundraising News Team
Aug 1, 2025
2 min read
HealthTech
MapLight Therapeutics

MapLight Therapeutics raises $372.5M Series D

MapLight Therapeutics raises $372.5M in Series D. Biopharma company developing medicines for brain disorders using novel drug discovery platform...

Editorial Team
Sep 29, 2025
1 min read$372.5M
Fundraising
Maplight

Maplight Raises $160M in Series C

Maplight, a AI/ML company based in San Francisco, CA, has raised $160M in Series C from multiple investors.

Fundraising News Team
Aug 2, 2025
2 min read
AI/ML
Maplight

Maplight raises $160M Series C

Maplight raises $160M in Series C. AI mapping and geospatial intelligence platform...

Editorial Team
Aug 2, 2025
1 min read$160M
HealthTech
Arnatar Therapeutics

Arnatar Therapeutics raises $52M Series A

Arnatar Therapeutics raises $52M in Series A. Developing therapeutics for autoimmune and inflammatory diseases...

Editorial Team
Aug 25, 2025
1 min read$52M
Biotech
Denali Therapeutics

Denali Therapeutics raises $217M Series C at $5B valuation

Denali Therapeutics raises $217M in Series C at $5B valuation. Neurodegeneration therapeutics...

Editorial Team
Mar 6, 2024
1 min read$217M
HealthTech
Strand Therapeutics

Strand Therapeutics raises $153M Series B

Strand Therapeutics raises $153M in Series B. mRNA-based therapeutics developer with novel cancer treatment platform...

Editorial Team
Sep 17, 2025
1 min read$153M
Biotech
Seres Therapeutics

Seres Therapeutics raises $113M Series E at $450M valuation

Seres Therapeutics raises $113M in Series E at $450M valuation. Microbiome therapeutic platform...

Editorial Team
Jan 19, 2024
1 min read$113M
Biotech
Crystalys Therapeutics

Crystalys Therapeutics raises $205M Series B at $900M valuation

Crystalys Therapeutics raises $205M in Series B at $900M valuation. Developing novel therapeutics for neurodegenerative diseases...

Editorial Team
Oct 1, 2025
1 min read$205M
Page 1

Showing 9 reports • Page 1 • Category: all

Stay ahead of the market

Get weekly insights delivered to your inbox. No spam, just intelligence.